門場　啓一郎

門場　啓一郎

  • 門場　啓一郎（かどば　けいいちろう）
  • 資格
    日本内科学会　認定内科医、日本リウマチ学会　リウマチ専門医

ひとこと

リウマチ性疾患の診断治療が日進月歩で発展する現代に臨床や研究に携われることに感謝しつつ, 日々全力で取り組んでまいります.

略歴

2015年 京都大学医学部医学科　卒業
2015年〜2017年 京都大学医学部附属病院 初期臨床研修医
2017年〜2020年 倉敷中央病院　内分泌代謝・リウマチ内科　シニアレジデント
2020年 京都大学大学院医学研究科　臨床免疫学　大学院生

業績

    1. Fuseya Y, Kadoba K (co-first), Liu X, Suetsugu H, Iwasaki T, Ohmura K, Sumida T, Kochi Y, Morinobu A, Terao C, Iwai K. Attenuation of HOIL-1L ligase activity promotes systemic autoimmune disorders by augmenting linear ubiquitin signaling. JCI Insight. 2024 Feb 8;9(3):e171108. doi: 10.1172/jci.insight.171108. PMID: 38329126.
    2. Manabe A, Kadoba K, Hiwa R, Kotani T, Shoji M, Shirakashi M, Tsuji H, Kitagori K, Akizuki S, Nakashima R, Yoshifuji H, Yamamoto W, Okazaki A, Matsuda S, Gon T, Watanabe R, Hashimoto M, Morinobu A. Risk factors for serious infections and infection-related mortality in patients with microscopic polyangiitis: Multicentre REVEAL cohort study. Mod Rheumatol. 2024 Mar 29:roae024. doi: 10.1093/mr/roae024. Epub ahead of print. PMID: 38564330.
    3. Yamaguchi E, Kadoba K (co-first), Watanabe R, Iwasaki T, Kitagori K, Akizuki S, Murakami K, Nakashima R, Hashimoto M, Tanaka M, Morinobu A, Yoshifuji H. Clinical profile and outcome of large-vessel giant cell arteritis in Japanese patients: a single-center retrospective cohort study. Modern Rheumatol. 2022 Feb 9;roac013. doi: 10.1093/mr/roac013.Online ahead of print.
    4. Kadoba K, Watanabe R, Iwasaki T, Nakajima T, Kitagori K, Akizuki S, Murakami K, Nakashima R, Hashimoto M, Tanaka M, Ohmura K, Morinobu A, Terao C, Yoshifuji H. A susceptibility locus in the IL12B but not LILRA3 region is associated with vascular damage in Takayasu arteritis. Sci Rep. 2021 Jul 1;11(1):13667. doi: 10.1038/s41598-021-93213-9.
    5. Kitada T, Kadoba K (co-first), Watanabe R, Koyama T, Nakayama Y, Taki M, Yukawa S, Odani K, Morinobu A. Listeriosis presenting with fever, arthralgia, elevated liver enzymes, and hyperferritinaemia in pregnancy: a critical mimicker of adult-onset Still’s disease. Scand J Rheumatol. 2022 Jan;51(1):78-80.
       doi: 10.1080/03009742.2021.1923149. Epub 2021 Jun 21.
    6. Kadoba K, Nishimura K, Waki D, Okada T, Kumazawa T, Saito R, Murabe H, Yokota T. Black-blood magnetic resonance imaging suggesting central nervous system vasculitis in moyamoya syndrome associated with systemic lupus erythematosus. Immunol Med. 2021 Dec;44(4):270-273.
    7. Kadoba K, Nishimura K, Uchino K, Waki D, Murabe H, Yokota T. Age-related Epstein-Barr Virus-associated Lymphoproliferative Disorder Masquerading as Systemic Lupus Erythematosus. Intern Med. 2021 Aug 1;60(15):2495-2497.
    8. Kadoba K, Waki D, Nishimura K, Mukoyama H, Saito R, Murabe H, Yokota T. Development of severe thrombocytopenia with TAFRO syndrome-like features in a patient with rheumatoid arthritis treated with a Janus kinase inhibitor. Medicine (Baltimore). 2020;99(42):e22793.
    9. Kadoba K, Mizukawa K, Nishimura K, Murabe H. Large vessel giant cell arteritis suggested by magnetic resonance imaging of the thigh: a potential mimicker of myositis, fasciitis and skeletal muscle vasculitis. Rheumatology (Oxford). 2019;58(12):2211.
    10. 門場啓一郎, 吉藤元. 最新の診断・治療アプローチに基づく巨細胞性動脈炎のtreat-to-target戦略. リウマチ科.2023;70(4):424-432.
    11. 門場啓一郎, 吉藤元. 血管炎の革新的進展　診断と治療の最先端. 医学のあゆみ.2024;288(5):425-432.
    12. 門場啓一郎, 辻英輝. 全身性エリテマトーデスと自己抗体. 皮膚科.2024;5(3):247-254.

ページトップへ